News articles about NanoString Technologies (NASDAQ:NSTG) have trended somewhat positive recently, according to Accern Sentiment. Accern identifies positive and negative news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. NanoString Technologies earned a news impact score of 0.11 on Accern’s scale. Accern also assigned media headlines about the biotechnology company an impact score of 46.2534803058389 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
These are some of the media headlines that may have impacted Accern Sentiment’s scoring:
- NanoString Technologies (NSTG) Stock Rating Upgraded by Zacks Investment Research (americanbankingnews.com)
- NanoString Technologies, Inc. :NSTG-US: Earnings Analysis: Q3, 2017 By the Numbers : January 1, 2018 (finance.yahoo.com)
- Head to Head Review: NanoString Technologies (NSTG) vs. IRIS International (IRIS) (americanbankingnews.com)
- ETFs with exposure to NanoString Technologies, Inc. : December 28, 2017 (finance.yahoo.com)
Shares of NanoString Technologies (NASDAQ:NSTG) traded up $0.33 during trading on Wednesday, reaching $7.80. 148,000 shares of the company’s stock were exchanged, compared to its average volume of 172,150. The company has a debt-to-equity ratio of 1.08, a current ratio of 3.35 and a quick ratio of 2.89. NanoString Technologies has a twelve month low of $7.03 and a twelve month high of $23.25. The firm has a market cap of $189.61, a price-to-earnings ratio of -3.77 and a beta of 0.82.
NSTG has been the subject of several recent research reports. Robert W. Baird reduced their price target on shares of NanoString Technologies from $14.00 to $12.00 and set an “outperform” rating for the company in a report on Friday, November 3rd. Zacks Investment Research lowered shares of NanoString Technologies from a “hold” rating to a “sell” rating in a research note on Tuesday, October 17th. Cowen reiterated a “buy” rating and set a $20.00 price objective on shares of NanoString Technologies in a research note on Thursday, September 28th. Finally, Janney Montgomery Scott lowered shares of NanoString Technologies from a “buy” rating to a “neutral” rating in a research note on Thursday, October 12th. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $15.06.
COPYRIGHT VIOLATION WARNING: This story was originally reported by Community Financial News and is owned by of Community Financial News. If you are viewing this story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this story can be viewed at https://www.com-unik.info/2018/01/03/somewhat-positive-media-coverage-somewhat-unlikely-to-impact-nanostring-technologies-nstg-stock-price.html.
NanoString Technologies Company Profile
NanoString Technologies, Inc develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample.
Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.